- Home
- CRGY vs DYN Comparison
CRGY vs DYN Comparison
Compare CRGY & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRGY | DYN |
|---|---|---|
| Founded | 1986 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medicinal Chemicals and Botanical Products |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.9B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | CRGY | DYN |
|---|---|---|
| Price | $8.96 | $19.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 16 |
| Target Price | $14.22 | ★ $40.25 |
| AVG Volume (30 Days) | ★ 4.8M | 3.4M |
| Earning Date | 11-03-2025 | 11-05-2025 |
| Dividend Yield | ★ 5.11% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $3,590,024,000.00 | N/A |
| Revenue This Year | $29.14 | N/A |
| Revenue Next Year | $30.46 | N/A |
| P/E Ratio | $90.51 | ★ N/A |
| Revenue Growth | ★ 32.31 | N/A |
| 52 Week Low | $6.83 | $6.36 |
| 52 Week High | $16.94 | $27.59 |
Technical Indicators
Market Signals| Indicator | CRGY | DYN |
|---|---|---|
| Relative Strength Index (RSI) | 43.65 | 48.13 |
| Support Level | $9.35 | $18.21 |
| Resistance Level | $9.71 | $20.80 |
| Average True Range (ATR) | 0.32 | 1.46 |
| MACD | -0.06 | -0.29 |
| Stochastic Oscillator | 4.55 | 20.96 |
Price Performance
Historical ComparisonAbout CRGY Crescent Energy Company
Crescent Energy Co is an independent energy company with a portfolio of assets in key basins across the lower 48 states. The company maintains a diverse portfolio of assets in key basins across the United States, including the Eagle Ford, Rockies, Barnett, Permian, and Mid-Con. It seeks to deliver attractive risk-adjusted investment returns and predictable cash flows across cycles with a focus on operated oil and gas assets complemented by non-operated assets, mineral and royalty interests, and midstream infrastructure.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.